News | Cardiac Imaging | April 26, 2023

Laser Speckle Imaging can Identify Hearts Suitable for Transplantation

Researchers use a new, speckle-based, noninvasive technique to visualize microvasculature in donor hearts and detect abnormal blood flow 

Researchers use a new, speckle-based, noninvasive technique to visualize microvasculature in donor hearts and detect abnormal blood flow

A powerful tool for imaging donor hearts, laser speckle captures detailed images of blood vessels in a beating heart outside the body. Plyer et al., doi 10.1117/1.JBO.28.4.046007.


April 26, 2023 — In the majority of cases, graft failure after heart transplantation is attributable to abnormalities like severe coronary artery disease. As donors with extended criteria like advanced age and pre-existing heart conditions become eligible for heart transplantation, careful screening for congenital abnormalities has become crucial. Invasive coronary angiography is an essential screening tool that can detect coronary artery disease (CAD), a condition characterized by cholesterol deposits in the heart's arteries. However, logistical challenges limit utility so it’s used for fewer than a third of donors who are at risk of developing CAD. 

To overcome this limitation, a new heart preservation procedure called “ex situ heart perfusion” (ESHP) has been developed. By allowing the supply of oxygenated nutrients to the heart via blood vessels, ESHP allows doctors to monitor the performance of the heart and screen it for any defects outside the body. However, coronary angiography conducted during ESHP is known to damage the heart and result in primary graft failure. Alternative coronary imaging tools are, therefore, required to identify abnormal blood flows in donor hearts and to determine their eligibility for transplantation. 


As reported in the Journal of Biomedical Optics (JBO), a team of researchers led by Professor Elise Colin from Paris Saclay University, France, introduced a safe and noninvasive optical technique that allows imaging of coronary blood circulation in donor hearts during ESHP. The method utilizes a recently developed speckle imaging technique, known as Laser Speckle Orthogonal Contrast Imaging (LSOCI), that was developed to detect the multiple scattering of moving red blood cells. 

In this study, the researchers improved the imaging capability of LSOCI to observe small blood vessels in the heart. The proposed method thus analyzes blood flow in the heart using a specific polarimetric filtering process that allows suppression of surface scattering. Thus, the time varying speckle patterns used for the imaging process are mainly generated by multiple scattering on moving red blood cells inside peripheral vessels. 

“The optical technique allows high-resolution imaging of the entire peripheral vasculature of the heart in real time,” says Colin. 

To test this method, the researchers developed a clinical model to study coronary circulation on donor hearts before transplantation. They then used a laser and a camera mounted on an articulated arm fixed above the perfusion module—which contained the donor heart—to generate and analyze rapidly varying speckle patterns. 

To overcome the challenges in tracking vasculature due to the beating of the heart, the researchers further optimized the technique with a method called Multi-Period-Enhanced Signal-to-Noise Ratio (MPE-SNR). They took a series of images over time to build a set of frames that depicted the vasculature at similar heart positions. Each image in this sequence was then optimized using the other images to reduce noise and enhance details. The optimized image represented the vasculature at a different time point, and the researchers used a sequence of such images to visualize vasculatures as small as 100 microns in a few seconds. 

The newly developed imaging technique enables precise visualization of blood circulation. In the future, this technique can potentially identify myocardial perfusion abnormalities that indicate underlying heart conditions, such as coronary artery disease. 

According to Amy Oldenburg, Professor at the University of North Carolina at Chapel Hill and JBO Associate Editor, “The noncontact technique, based on laser speckle, provides imaging of blood circulation within donor hearts and has important implications for identifying hearts that are safe and suitable for transplantation." 

Here’s hoping that these findings can make heart transplantation surgeries safer and more successful for patients in need of this life-saving procedure. 

Read the Gold Open Access article by A. Plyer et al., “Imaging the vasculature of a beating heart by dynamic speckle: the challenge of a quasiperiodic motion,” J. Biomed. Opt. 28(4) 046007 (2023), doi 10.1117/1.JBO.28.4.046007

For more information: https://spie.org/?SSO=1


Related Content

News | Heart Failure

April 16, 2024 — Each year more than 500,000 Americans undergo percutaneous coronary intervention, or PCI, a minimally ...

Home April 16, 2024
Home
News | Heart Failure

April 12, 2024 — University of Virginia School of Medicine researchers have discovered a gene on the Y chromosome that ...

Home April 12, 2024
Home
News | Heart Failure

April 2, 2024 — People who use e-cigarettes are significantly more likely to develop heart failure compared with those ...

Home April 02, 2024
Home
News | Heart Failure

March 29, 2024 — V-Wave announced it will present late-breaking data from its RELIEVE-HF pivotal trial at the American ...

Home March 29, 2024
Home
News | Heart Failure

March 25, 2024 — A team of engineers led by the University of Massachusetts Amherst and including colleagues from the ...

Home March 25, 2024
Home
News | Heart Failure

March 15, 2024 — BioCardia, Inc. , a biotechnology company focused on advancing late-stage cell therapy interventions ...

Home March 15, 2024
Home
News | Heart Failure

March 15, 2024 — BioCardia, Inc., a biotechnology company focused on advancing late-stage cell therapy interventions for ...

Home March 15, 2024
Home
News | Heart Failure

March 13, 2024 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...

Home March 13, 2024
Home
News | Heart Failure

March 8, 2024 — The Texas Heart Institute, Georgia Institute of Technology (Georgia Tech), North Carolina State ...

Home March 08, 2024
Home
News | Heart Failure

March 5, 2024 — FIRE1 announced that it has completed patient enrollment in the U.S. Early Feasibility Study (FUTURE-HF2 ...

Home March 05, 2024
Home
Subscribe Now